Related Experiment Videos
Systemic kappa light-chain deposition. An ultrastructural and immunohistochemical study
Abstract:
This report describes the pathology of kappa light-chain deposition in a 55-year-old patient who presented with respiratory insufficiency and hepatomegaly. Biopsies of lung and liver showed PAS-positive deposits which did not stain with congo red, crystal violet, or thioflavin-T. By indirect immunoperoxidase techniques, the deposits were composed of kappa light-chain immunoglobin. Electron microscopy revealed granular and fibrillar electron-dense material which lacked the characteristics of amyloid. Subsequent clinical studies showed this patient had a plasma cell dyscrasia. These data show that kappa light-chain deposition is not limited to the kidney, and that the first manifestation of a plasma cell dyscrasia may be systemic deposits of light chain. These deposits can be distinguished from amyloid by their immunochemical, tinctorial, and ultrastructural appearance.
Insights
Kappa light-chain deposition disease can affect organs beyond the kidneys, presenting as systemic deposits. This condition is a distinct pathology from amyloidosis and signals underlying plasma cell dyscrasia.
Area of Science:
- Pathology
- Immunology
- Oncology
Background:
- Plasma cell dyscrasias can manifest with light chain deposition, typically affecting the kidneys.
- Distinguishing light chain deposition from amyloidosis is crucial for accurate diagnosis and treatment.
Observation:
- A 55-year-old patient presented with respiratory insufficiency and hepatomegaly, exhibiting non-amyloidotic PAS-positive deposits in lung and liver biopsies.
- Immunohistochemistry confirmed these deposits were composed of kappa light-chain immunoglobulin.
- Electron microscopy revealed granular and fibrillar electron-dense material, differing from amyloid ultrastructure.
Findings:
- Kappa light-chain deposition is not exclusive to renal pathology and can present systemically.
- These deposits can be differentiated from amyloidosis through immunochemical, tinctorial, and ultrastructural analyses.
- Systemic light chain deposition may be an early indicator of plasma cell dyscrasia.
Implications:
- This case expands the known organ involvement of kappa light-chain deposition disease.
- The findings highlight the importance of considering non-renal light chain deposition in diagnosing plasma cell dyscrasias.
- Accurate differentiation from amyloidosis is critical for appropriate patient management and therapeutic strategies.